Metraipolis › archive › dc_7a654cf6d85f

Assessing the Economic Benefit of Mass COVID-19 Vaccination Program in Iran: A Real-World Modeling Study — Europe PMC PMID:41966177

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41966177
DOI
10.34172/ijhpm.8852
License (as archived)
solo-consultazione
Archived
2026-11-09T09:51:29.199Z
SHA-256 of the archived text
396da4091d5e3f7fe4638d859b615fb479ea24d79fde16e754409bbe3f84afd5
Stable URL of this page
https://metraipolis.com/documento/dc_7a654cf6d85f

How to cite

Assessing the Economic Benefit of Mass COVID-19 Vaccination Program in Iran: A Real-World Modeling Study — Europe PMC PMID:41966177 — Europe PMC (en), https://europepmc.org/article/MED/41966177 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7a654cf6d85f (Metraipolis archive dc_7a654cf6d85f, sha256 396da4091d5e3f7fe4638d859b615fb479ea24d79fde16e754409bbe3f84afd5)
BibTeX
@misc{dc7a654cf6d85f,
  title = {Assessing the Economic Benefit of Mass COVID-19 Vaccination Program in Iran: A Real-World Modeling Study — Europe PMC PMID:41966177},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41966177},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7a654cf6d85f; sha256 396da4091d5e3f7fe4638d859b615fb479ea24d79fde16e754409bbe3f84afd5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41966177. Agents can read the archived copy with the MCP tool read_document.